Xiangming Qi
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
- Nephrology 26
- Chronic Kidney Disease and Diabetes 18
- Renal Diseases and Glomerulopathies 7
- Dialysis and Renal Disease Management 6
-
- Advanced Glycation End Products research 10
Xiangming Qi
50 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 104
- Nephrology 313
- Clinical Biochemistry 136
- Complementary and alternative medicine 160
- Pharmacology 108
- Immunology 208
Countries citing papers authored by Xiangming Qi
This map shows the geographic impact of Xiangming Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangming Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangming Qi more than expected).
Fields of papers citing papers by Xiangming Qi
This network shows the impact of papers produced by Xiangming Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangming Qi. The network helps show where Xiangming Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiangming Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 11 | |
| 8 | 2022 | 20 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 54 | |
| 11 | 2021 | 18 | |
| 12 | 2017 | 37 | |
| 13 | 2016 | 10 | |
| 14 | 2016 | 6 | |
| 15 | 2016 | 28 | |
| 16 | 2016 | 17 | |
| 17 | 2015 | 30 | |
| 18 | 2014 | 5 | |
| 19 | 2013 | 36 | |
| 20 | 2011 | 16 |
About Xiangming Qi
Xiangming Qi is a scholar working on Nephrology, Clinical Biochemistry, Immunology, Transplantation and Complementary and alternative medicine, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (18 papers), Advanced Glycation End Products research (10 papers), Immune cells in cancer (9 papers), Renal Diseases and Glomerulopathies (7 papers), Dialysis and Renal Disease Management (6 papers), Immune Response and Inflammation (5 papers), Traditional Chinese Medicine Analysis (4 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Nephrology (313 citations), Clinical Biochemistry (136 citations), Complementary and alternative medicine (160 citations), Pharmacology (108 citations) and Immunology (208 citations). Xiangming Qi has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Yonggui Wu, Jijia Shen, Xingxin Xu, Pei Zhang, Kun Wang, Xue‐qi Liu, Jing Su, Lingling Xia, Ling Jiang and Jing Zhao. Their work appears in journals such as International Immunopharmacology, Inflammation Research, Renal Failure, Phytomedicine and Blood Purification.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.